4 completed, 3 recruiting, 1 terminated, 1 unknown. 9 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 9 | Completed 4, Recruiting 3, Terminated 1, Unknown 1 |
Follow Feraheme: new trials by email Literature Review of Feraheme trials Research Report on Feraheme
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Advanced Imaging Techniques for Evaluating the Tumor Immune Microenvironment in Glioblastoma Patients Biospecimen Collection, Chemical Exchange Saturation Transfer Magnetic Resonance Imaging, Diffusion-Relaxation Correlation Spectrum Imaging - Glioblastoma | Phase 3 | Recruiting | Jonsson Comprehensive Cancer Center | 15 | 2025-10-27 | 2026-03-10 |
| A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects ferumoxytol, Iron sucrose - Iron Deficiency Anemia | Phase 3 | Recruiting | AMAG Pharmaceuticals, Inc. | 75 | 2019-09-18 | 2026-04-17 |
| A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD) Ferumoxytol, Iron sucrose - Chronic Kidney Disease; Iron Deficiency Anemia | Phase 3 | Recruiting | AMAG Pharmaceuticals, Inc. | 129 | 2018-08-13 | 2026-04-17 |
| Ferumoxytol-enhanced Magnetic Resonance Imaging ferumoxytol - Coronary Artery Disease | Phase 3 | Unknown | Brigham and Women's Hospital | 185 | 2017-02-01 | 2023-01-04 |
| A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA) Ferumoxytol, FCM - Iron Deficiency Anemia | Phase 3 | Completed | AMAG Pharmaceuticals, Inc. | 2014 | 2016-02-29 | 2023-07-25 |
| A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease Ferumoxytol - Iron Deficiency Anemia | Phase 3 | Terminated | AMAG Pharmaceuticals, Inc. | 8 | 2011-12-27 | 2022-04-28 |
| A Trial Comparing Ferumoxytol With Iron Sucrose for the Treatment of Iron Deficiency Anemia Ferumoxytol, Iron Sucrose - Iron Deficiency Anemia | Phase 3 | Completed | AMAG Pharmaceuticals, Inc. | 605 | 2010-08-10 | 2022-04-21 |
| A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia Ferumoxytol - Iron Deficiency Anemia | Phase 3 | Completed | AMAG Pharmaceuticals, Inc. | 634 | 2010-07-27 | 2022-04-21 |
| A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia Ferumoxytol, Placebo - Iron Deficiency Anemia | Phase 3 | Completed | AMAG Pharmaceuticals, Inc. | 812 | 2010-06-19 | 2022-04-21 |
Anemia, Iron-Deficiency (7) · Renal Insufficiency, Chronic (2) · Anemia (1) · Coronary Artery Disease (1) · Glioblastoma (1)
AMAG Pharmaceuticals, Inc. (7) · Brigham and Women's Hospital (1) · Jonsson Comprehensive Cancer Center (1)
United States (8) · Poland (6) · Hungary (5) · Latvia (4) · Lithuania (4) · Canada (3) · India (2) · Australia (1) · France (1) · Germany (1) · Italy (1) · Mexico (1) · Puerto Rico (1) · Romania (1) · South Africa (1)
Jingwen Yao (1)
KL2TR001882 (1)